Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Robinhood Accelerates Bid to Become Family Finance Super App

Mobile brokerage expands features to attract families seeking financial solutions.Highlights: Robinhood introduces new family-focused features.The platform aims to...

J.P. Morgan Payments Teams with Mirakl to Strengthen Agentic Commerce

Partnership aims to enhance online marketplace capabilities through innovative payment solutions.Highlights: J.P. Morgan Payments collaborates with Mirakl for...

UK Government Launches New Online Crime Squad to Combat Cybercrime

Specialized unit aims to enhance online safety and counter digital crime.Highlights: The UK government unveiled a new online...

NYSE Faces $9 Million Fine from SEC Over Trading Glitch

Regulatory action follows significant trading errors affecting market operations.Highlights: NYSE fined $9 million by SEC for a trading...